Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology in Uppsala, Sweden

Journal of Hematopathology

Volumn 5, Issue 3, 2012, Pages 169-199

  Fend, Falko ^a   Cabecadas, José ^b   Gaulard, Philippe ^c   Jaffe, Elaine S ^d   Kluin, Philip ^e   Kuzu, Isinsu ^f   Peterson, LoAnn ^g   Wotherspoon, Andrew ^h   Sundström, Christer ⁱ  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^c HENRI MONDOR HOSPITAL   (France)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ANKARA UNIVERSITY   (Turkey)

^g NORTHWESTERN UNIVERSITY   (United States)

^h ROYAL MARSDEN HOSPITAL   (United Kingdom)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Lymphoma classification; Lymphoma in situ; Lymphoma workshop; Monoclonal B cell lymphocytosis; Premalignant lymphoid proliferations; Virus associated lymphoproliferations

Indexed keywords

EID: 84879102622     PISSN: None     EISSN: 18655785     Source Type: Journal    
DOI: 10.1007/s12308-012-0148-6     Document Type: Article

References (134)

1. Campo E, Chott A, Kinney MC, Leoncini L, Meijer CJ, Papadimitriou CS et al (2006) Update on extranodal lymphomas. Conclusions of the workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology 48: 481-504.
2. Quintanilla-Martinez L, de Jong D, de Mascarel A, Hsi ED, Kluin P, Natkunam Y et al (2009) Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV Meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematop 2: 211-236.
3. Lennert K, Muller-Hermelink HK (1975) Lymphocytes and their functional forms-morphology, organization and immunologic significance. Verh Anat Ges 69: 19-62.
4. Osborne BM, Butler JJ, Gresik MV (1992) Progressive transformation of germinal centers: comparison of 23 pediatric patients to the adult population. Mod Pathol 5: 135-140.
5. Ferry JA, Zukerberg LR, Harris NL (1992) Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease. Am J Surg Pathol 16: 252-258.
6. Poppema S, Kaiserling E, Lennert K (1979) Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres-a cytohistological study. Histopathology 3: 295-308.
7. Poppema S, Kaiserling E, Lennert K (1979) Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol 31: 211-225.
8. Brauninger A, Yang W, Wacker HH, Rajewsky K, Kuppers R, Hansmann ML (2001) B-cell development in progressively transformed germinal centers: similarities and differences compared with classical germinal centers and lymphocyte-predominant Hodgkin disease. Blood 97: 714-719.
9. Hansmann ML, Fellbaum C, Hui PK, Moubayed P (1990) Progressive transformation of germinal centers with and without association to Hodgkin's disease. Am J Clin Pathol 93: 219-226.
10. + T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J Clin Pathol 126: 805-814.
11. Chang CC, Osipov V, Wheaton S, Tripp S, Perkins SL (2003) Follicular hyperplasia, follicular lysis, and progressive transformation of germinal centers. A sequential spectrum of morphologic evolution in lymphoid hyperplasia. Am J Clin Pathol 120: 322-326.
12. Nguyen PL, Ferry JA, Harris NL (1999) Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study. Am J Surg Pathol 23: 27-33.
13. Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES (2003) Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 27: 522-531.
14. Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Dominguez-Franjo P et al (2008) PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32: 1252-1257.
15. Kussick SJ, Kalnoski M, Braziel RM, Wood BL (2004) Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol 121: 464-472.
16. Finn LS, Viswanatha DS, Belasco JB, Snyder H, Huebner D, Sorbara L et al (1999) Primary follicular lymphoma of the testis in childhood. Cancer 85: 1626-1635.
17. Lorsbach RB, Shay-Seymore D, Moore J, Banks PM, Hasserjian RP, Sandlund JT et al (2002) Clinicopathologic analysis of follicular lymphoma occurring in children. Blood 99: 1959-1964.
18. Oschlies I, Salaverria I, Mahn F, Meinhardt A, Zimmermann M, Woessmann W et al (2010) Pediatric follicular lymphoma-a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma-Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials. Haematologica 95: 253-259.
19. Swerdlow SH (2004) Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia. Am J Clin Pathol 122(Suppl): S98-S109.
20. Sheibani K, Sohn CC, Burke JS, Winberg CD, Wu AM, Rappaport H (1986) Monocytoid B-cell lymphoma. A novel B-cell neoplasm. Am J Pathol 124: 310-318.
21. Salama ME, Lossos IS, Warnke RA, Natkunam Y (2009) Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. Am J Clin Pathol 132: 39-49.
22. Elenitoba-Johnson KS, Kumar S, Lim MS, Kingma DW, Raffeld M, Jaffe ES (1997) Marginal zone B-cell lymphoma with monocytoid B-cell lymphocytes in pediatric patients without immunodeficiency. A report of two cases. Am J Clin Pathol 107: 92-98.
23. Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M et al (2010) Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol 23: 866-873.
24. Gitelson E, Al-Saleem T, Robu V, Millenson MM, Smith MR (2010) Pediatric nodal marginal zone lymphoma may develop in the adult population. Leuk Lymphoma 51: 89-94.
25. Attygalle AD, Liu H, Shirali S, Diss TC, Loddenkemper C, Stein H et al (2004) Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood 104: 3343-3348.
26. Kojima M, Nakamura S, Itoh H, Yoshida K, Shimizu K, Motoori T et al (1998) Occurrence of monocytoid B-cells in reactive lymph node lesions. Pathol Res Pract 194: 559-565.
27. Hunt JP, Chan JA, Samoszuk M, Brynes RK, Hernandez AM, Bass R et al (2001) Hyperplasia of mantle/marginal zone B cells with clear cytoplasm in peripheral lymph nodes. A clinicopathologic study of 35 cases. Am J Clin Pathol 116: 550-559.
28. Kojima M, Nakamura S, Tanaka H, Yamane Y, Sugihara S, Masawa N (2003) Massive hyperplasia of marginal zone B-cells with clear cytoplasm in the lymph node: a case report. Pathol Res Pract 199: 625-628.
29. Kojima M, Motoori T, Iijima M, Ono T, Yoshizumi T, Matsumoto M et al (2006) Florid monocytoid B-cell hyperplasia resembling nodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue type. A histological and immunohistochemical study of four cases. Pathol Res Pract 202: 877-882.
30. Kojima M, Nakamura S, Motoori T, Shimizu K, Ohno Y, Itoh H et al (2002) Follicular hyperplasia presenting with a marginal zone pattern in a reactive lymph node lesion. APMIS 110: 325-331.
31. Viswanatha DS, Dogan A (2007) Hepatitis C virus and lymphoma. J Clin Pathol 60: 1378-1383.
32. + B cells in HCV-associated mixed cryoglobulinemia. Blood 111: 1344-1356.
33. Curry MP, Golden-Mason L, Doherty DG, Deignan T, Norris S, Duffy M et al (2003) Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol 38: 642-650.
34. Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K et al (2002) Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 128: 353-358.
35. Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES (1992) Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol 16: 1170-1182.
36. Au WY, Horsman DE, Connors JM, Klasa RJ, Gascoyne RD (2002) Cytogenetic findings in reactive lymphoid hyperplasia: significance of non-clonal t(3; 14) and t(3; 22). Am J Hematol 70: 133-138.
37. Gordon DS, Jones BM, Browning SW, Spira TJ, Lawrence DN (1982) Persistent polyclonal lymphocytosis of B lymphocytes. N Engl J Med 307: 232-236.
38. Troussard X, Flandrin G (1996) Chronic B-cell lymphocytosis with binucleated lymphocytes (LWBL): a review of 38 cases. Leuk Lymphoma 20: 275-279.
39. Casassus P, Lortholary P, Komarover H, Lejeune F, Hors J (1987) Cigarette smoking-related persistent polyclonal B lymphocytosis. A premalignant state. Arch Pathol Lab Med 111: 1081.
40. Delage R, Jacques L, Massinga-Loembe M, Poulin J, Bilodeau D, Mignault C et al (2001) Persistent polyclonal B-cell lymphocytosis: further evidence for a genetic disorder associated with B-cell abnormalities. Br J Haematol 114: 666-670.
41. Machii T, Yamaguchi M, Inoue R, Tokumine Y, Kuratsune H, Nagai H et al (1997) Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant. Blood 89: 2008-2014.
42. Himmelmann A, Gautschi O, Nawrath M, Bolliger U, Fehr J, Stahel RA (2001) Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD(+)CD27(+) memory B cells. Br J Haematol 114: 400-405.
43. Loembe MM, Lamoureux J, Deslauriers N, Darveau A, Delage R (2001) Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis. Br J Haematol 113: 699-705.
44. Larcher C, Fend F, Mitterer M, Prang N, Schwarzmann F, Huemer HP (1995) Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis. Br J Haematol 90: 532-540.
45. Mossafa H, Troussard X, Valensi F, Schillinger F, Maynadie M, Bulliard G et al (1996) Isochromosome i(3q) and premature chromosome condensation are recurrent findings in chronic B-cell lymphocytosis with binucleated lymphocytes. Leuk Lymphoma 20: 267-273.
46. Callet-Bauchu E, Gazzo S, Poncet C, Pages J, Morel D, Alliot C et al (1999) Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis. Gene Chromosome Canc 26: 221-228.
47. Delage R, Roy J, Jacques L, Darveau A (1998) All patients with persistent polyclonal B cell lymphocytosis present Bcl-2/Ig gene rearrangements. Leuk Lymphoma 31: 567-574.
48. Cornet E, Lesesve JF, Mossafa H, Sebahoun G, Levy V, Davi F et al (2009) Long-term follow-up of 111 patients with persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes. Leukemia 23: 419-422.
49. Del Giudice I, Pileri SA, Rossi M, Sabattini E, Campidelli C, Starza ID et al (2009) Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. Br J Haematol 144: 726-731.
50. Feugier P, De March AK, Lesesve JF, Monhoven N, Dorvaux V, Braun F et al (2004) Intravascular bone marrow accumulation in persistent polyclonal lymphocytosis: a misleading feature for B-cell neoplasm. Mod Pathol 17: 1087-1096.
51. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC (2010) Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 24: 512-520.
52. Dagklis A, Fazi C, Sala C, Cantarelli V, Scielzo C, Massacane R et al (2009) The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood 114: 26-32.
53. Lanasa MC, Allgood SD, Volkheimer AD, Gockerman JP, Whitesides JF, Goodman BK et al (2010) Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis. Leukemia 24: 133-140.
54. Rawstron AC, Hillmen P (2011) Clinical and diagnostic implications of monoclonal B-cell lymphocytosis. Best Pract Res Clin Haematol 23: 61-69.
55. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE (2009) B-cell clones as early markers for chronic lymphocytic leukemia. New Engl J Med 360: 659-667.
56. Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A et al (2010) Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 78(Suppl 1): S19-S23.
57. Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E et al (2003) A subset of t(11; 14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101: 4975-4981.
58. Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A et al (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70: 1408-1418.
59. Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B et al (2008) The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol 143: 248-252.
60. Waldenstrom J (1952) Three new cases of purpura hyperglobulinemica. A study in long-lasting benign increase in serum globulin. Acta Med Scand Suppl 266: 931-946.
61. Kyle RA (1978) Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 64: 814-826.
62. Kyle RA, Rajkumar SV (2007) Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Br J Haematol 139: 730-743.
63. Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM (2009) A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 113: 5418-5422.
64. Shao H, Xi L, Raffeld M, Pittaluga S, Dunleavy K, Wilson WH et al (2010) Nodal and extranodal plasmacytomas expressing immunoglobulin A: an indolent lymphoproliferative disorder with a low risk of clinical progression. Am J Surg Pathol 34: 1425-1435.
65. Weyers W, Ende Y, Schalla W, Diaz-Cascajo C (2002) Balanitis of Zoon: a clinicopathologic study of 45 cases. Am J Dermatopathol 24: 459-467.
66. Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES (2002) In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 99: 3376-3382.
67. Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ et al (1991) Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6: 2271-2276.
68. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ et al (1995) Lymphoma-associated translocation t(14; 18) in blood B cells of normal individuals. Blood 85: 2528-2536.
69. Roulland S, Lebailly P, Lecluse Y, Heutte N, Nadel B, Gauduchon P (2006) Long-term clonal persistence and evolution of t(14; 18)-bearing B cells in healthy individuals. Leukemia 20: 158-162.
70. Roulland S, Lebailly P, Lecluse Y, Briand M, Pottier D, Gauduchon P (2004) Characterization of the t(14; 18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res 64: 2264-2269.
71. Cheung MC, Bailey D, Pennell N, Imrie KR, Berinstein NL, Amato D et al (2009) In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node. Leukemia 23: 1176-1179.
72. Henopp T, Quintanilla-Martinez L, Fend F, Adam P (2011) Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology 59: 139-142.
73. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S et al (2011) Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood 118: 2976-2984.
74. Schmatz AI, Streubel B, Kretschmer-Chott E, Puspok A, Jager U, Mannhalter C et al (2011) Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol 29: 1445-1451.
75. Adam P, Katzenberger T, Eifert M, Ott MM, Rosenwald A, Muller-Hermelink HK et al (2005) Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol 29: 1661-1664.
76. Campo E, Raffeld M, Jaffe ES (1999) Mantle cell lymphoma. Semin Hematol 36: 115-127.
77. Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY et al (2012) In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 97: 270-278.
78. Espinet B, Sole F, Pedro C, Garcia M, Bellosillo B, Salido M et al (2005) Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma? Hum Pathol 36: 1232-1237.
79. Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH (2003) Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol 34: 1030-1034.
80. Richard P, Vassallo J, Valmary S, Missoury R, Delsol G, Brousset P (2006) "In situ-like" mantle cell lymphoma: a report of two cases. J Clin Pathol 59: 995-996.
81. Aqel N, Barker F, Patel K, Naresh KN (2008) In-situ mantle cell lymphoma-a report of two cases. Histopathology 52: 256-260.
82. Gao J, Peterson L, Nelson B, Goolsby C, Chen YH (2009) Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol 132: 699-706.
83. Hirt C, Schuler F, Dolken L, Schmidt CA, Dolken G (2004) Low prevalence of circulating t(11; 14)(q13; q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood 104: 904-905.
84. Lecluse Y, Lebailly P, Roulland S, Gac AC, Nadel B, Gauduchon P (2009) t(11; 14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia 23: 1190-1193.
85. Chen YH, Gao J, Fan G, Peterson LC (2010) Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11; 14)(q13; q32) in non-mantle cell B-cell neoplasms. Mod Pathol 23: 105-112.
86. Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S et al (2009) Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica 94: 1563-1568.
87. Mozos A, Royo C, Hartmann E, De Jong D, Baro C, Valera A et al (2009) SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94: 1555-1562.
88. Fend F, Quintanilla-Martinez L, Kumar S, Beaty MW, Blum L, Sorbara L et al (1999) Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection. Am J Pathol 154: 1857-1866.
89. Roullet MR, Martinez D, Ma L, Fowler MH, McPhail ED, Judkins A et al (2010) Coexisting follicular and mantle cell lymphoma with each having an in situ component: a novel, curious, and complex consultation case of coincidental, composite, colonizing lymphoma. Am J Clin Pathol 133: 584-591.
90. Kim B, Roth C, Chung KC, Young VL, van Busum K, Schnyer C et al (2011) Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg 127: 2141-2150.
91. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A (2008) Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 21: 455-463.
92. Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K et al (2010) Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116: 5631-5637.
93. Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011) NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood 117: 1447-1452.
94. de Leval L, Gisselbrecht C, Gaulard P (2010) Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 148: 673-689.
95. Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26: 4124-4130.
96. Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ et al (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99: 627-633.
97. Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA (2009) Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol 22: 753-761.
98. Ree HJ, Kadin ME, Kikuchi M, Ko YH, Go JH, Suzumiya J et al (1998) Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol 22: 643-55.
99. Lachenal F, Berger F, Ghesquieres H, Biron P, Hot A, Callet-Bauchu E et al (2007) Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Med (Baltimore) 86: 282-292.
100. Tan BT, Warnke RA, Arber DA (2006) The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 8: 466-475.
101. Vrsalovic MM, Korac P, Dominis M, Ostojic S, Mannhalter C, Kusec R (2004) T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma. Hematol Oncol 22: 169-177.
102. Mourad N, Mounier N, Briere J, Raffoux E, Delmer A, Feller A et al (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 111: 4463-4470.
103. Zettl A, Lee SS, Rudiger T, Starostik P, Marino M, Kirchner T et al (2002) Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 117: 368-379.
104. Willenbrock K, Brauninger A, Hansmann ML (2007) Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 138: 733-739.
105. Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, Wotherspoon AC et al (2007) Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 31: 1077-1088.
106. Huang Y, Moreau A, Dupuis J, Streubel B, Petit B, Le Gouill S et al (2009) Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 33: 682-690.
107. Bacon CM, Paterson JC, Liu H, Payne K, Munson P, Du MQ et al (2008) Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma. Br J Haematol 143: 439-441.
108. + phenotype. Am J Surg Pathol 25: 395-400.
109. Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A (2006) Novel t(5; 9)(q33; q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 20: 313-318.
110. Wohrer S, Chott A, Drach J, Puspok A, Hejna M, Hoffmann M et al (2004) Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Ann Oncol 15: 1680-1683.
111. Ferreri AJ, Zinzani PL, Govi S, Pileri SA (2011) Enteropathy-associated T-cell lymphoma. Crit Rev Oncol Hematol 79: 84-90.
112. Al-Toma A, Goerres MS, Meijer JW, Pena AS, Crusius JB, Mulder CJ (2006) Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 4: 315-319.
113. van de Water JM, Cillessen SA, Visser OJ, Verbeek WH, Meijer CJ, Mulder CJ (2010) Enteropathy associated T-cell lymphoma and its precursor lesions. Best Pract Res Clin Gastroenterol 24: 43-56.
114. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG (1997) Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 151: 493-498.
115. Cellier C, Delabesse E, Helmer C, Patey N, Matuchansky C, Jabri B et al (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 356: 203-208.
116. Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M et al (2008) Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin Immunol 126: 48-56.
117. Malamut G, El Machhour R, Montcuquet N, Martin-Lanneree S, Dusanter-Fourt I, Verkarre V et al (2010) IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 120: 2131-2143.
118. Mention JJ, Ben Ahmed M, Begue B, Barbe U, Verkarre V, Asnafi V et al (2003) Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125: 730-745.
119. +CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 153: 1483-1490.
120. Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, Chari R et al (2007) Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 132: 1902-1911.
121. Vega F, Chang CC, Schwartz MR, Preti HA, Younes M, Ewton A et al (2006) Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am J Surg Pathol 30: 539-544.
122. Kim B, Roth C, Young VL, Chung KC, van Busum K, Schnyer C et al (2011) Anaplastic large cell lymphoma and breast i{dotless}mplants: results from a structured expert consultation process. Plast Reconstr Surg 128: 629-639.
123. Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G (2009) Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 50: 831-833.
124. Straus SE (1992) Acute progressive Epstein-Barr virus infections. Annu Rev Med 43: 437-449.
125. Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS et al (2008) Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58: 209-217.
126. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES (2009) Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 20: 1472-1482.
127. Quintanilla-Martinez L, Kimura H, Jaffe ES (2008) EBV-positive T-cell lymphoproliferative disorders of childhood. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon.
128. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM et al (2011) Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 117: 5835-5849.
129. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D et al (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95: 1406-1412.
130. Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J et al (2002) KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 100: 3415-3418.
131. Ferry JA, Sohani AR, Longtine JA, Schwartz RA, Harris NL (2009) HHV8-positive, EBV-positive Hodgkin lymphoma-like large B-cell lymphoma and HHV8-positive intravascular large B-cell lymphoma. Mod Pathol 22: 618-626.
132. Carbone A, Gloghini A, Santoro A (2012) In situ follicular lymphoma: pathologic characteristics and diagnostic features. Hematol Oncol 30: 1-7. doi: 10. 1002/hon. 993.
133. Ghia P (2011) Another piece of the puzzle: is there a "nodal" monoclonal B-cell lymphocytosis? Haematologica 96: 1089-1091.
134. Gibson SE, Swerdlow SH, Ferry JA, Surti U, Dal Cin P, Harris NL et al (2011) Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 96: 1144-1152.